PLUS THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Plus Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Plus Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$776K, a 257% decline year-over-year.
  • Plus Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.45M, a 74.4% decline from 2022.
  • Plus Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $13.5M, a 34.1% decline from 2021.
  • Plus Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $20.4M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$776K -$1.27M -257% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $493K -$6.8M -93.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $7.29M -$1.9M -20.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-20
Q1 2021 $9.19M +$9.21M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-21
Q1 2020 -$18K -$1.91M -101% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q1 2019 $1.89M +$2.04M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 -$150K Jan 1, 2018 Mar 31, 2018 8-K 2019-09-10
Q1 2014 $6.9M +$6.56M +1977% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q1 2013 $332K -$4.88M -93.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $5.22M +$4.54M +674% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $674K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.